Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 38c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $34.06 -0.06%
EPS Growth %: -27.8%
Financial Fact:
NET INCOME (LOSS): 20.17K
Today's EPS Names:
PMCB, PLCE, DOMO, More
EPS Growth %: -27.8%
Financial Fact:
NET INCOME (LOSS): 20.17K
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($1.20), $0.38 worse than the analyst estimate of ($0.82).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
- Palo Alto Networks (PANW) call put ratio 1 call to 1.1 puts into quarter results
- Credo Tech (CRDO) call put ratio 1 call to 1 put into quarter results
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
